New Treatment Option for Parkinson Disease

Dr. Jeff Ratliff, a medical expert in neurology, discusses the groundbreaking FDA approval of Crexant, a new extended-release medication for Parkinson's disease. He delves into its potential to improve motor function and shares insights from the RISE PD trial. The conversation also covers the formulation of the drug and its implications for clinical practice, offering hope for those affected by this challenging condition.